Key Highlights

● The European Union delayed a vote on Tesla's Full Self-Driving software, leaving investors unsure when the technology can roll out more widely in the region.

● Reports pointed to production challenges facing the Optimus humanoid robot, one of Tesla's most ambitious long-term projects.

● The same morning, BNP Paribas Exane cut its price target on Tesla from $280 to $268 while keeping an Underperform rating.

● Tesla's decline stood out against an otherwise strong market, with megacap tech leading broad gains across the Dow and Nasdaq.

Tesla is valued less like a carmaker and more like a technology company, largely because of what it promises to become. On Friday, two pillars of that promise wobbled. The European Union delayed a vote on Tesla's (NASDAQ:TSLA) Full Self-Driving software, and reports pointed to production challenges facing the Optimus humanoid robot. Shares slid, ending among the decliners on an S&P 500 that rose 39.28 points to 7,743.41.

Future Bets, Present Worries

The timing did not help. The same morning, BNP Paribas Exane cut its price target from $280 to $268 and kept an Underperform rating. Plans to ramp up Semi truck production also failed to lift the mood.

Why the EU Vote Matters

Full Self-Driving is Tesla's advanced driver-assistance software, which the company hopes will eventually support autonomous driving. Regulatory approval in large markets is essential for expanding it, and Europe is one of the most important. A delayed vote means a delayed decision, which leaves investors unsure when, or whether, the software can roll out more widely in the region.

Regulatory timelines are notoriously hard to predict. Delays do not necessarily mean rejection, but they push back potential Revenue and can dampen enthusiasm among investors who have priced in faster progress.

The Optimus Question

Optimus is Tesla's humanoid robot project, one of the most ambitious parts of its long-term vision. Building a robot in large numbers is very different from building a prototype. Reports of production challenges touch a sensitive nerve: much of the optimism around Tesla rests on the idea that it can manufacture new products at scale.

Manufacturing hurdles are common with first-of-a-kind products. How quickly they are resolved often shapes how the market values the project, and investors tend to reward visible progress.

Musk's Busy Week

Chief executive Elon Musk had a high-profile week. He attended the White House state dinner for Xi Jinping on Thursday, alongside Nvidia's Jensen Huang, and outlined plans to more than double Nvidia chips at the Colossus 2 data centre by year-end. The Xi summit produced limited policy outcomes but no immediate Tariff escalation, and two more meetings on AI and trade are planned in Shenzhen in November.

Elsewhere the market was upbeat. The Dow Jones Industrial Average jumped 478.64 points to 51,828.62, snapping a three-week losing streak, and the Nasdaq Composite rose 129.34 points to 27,068.72. Megacap tech did much of the lifting and the VIX fell to 14.87. Tesla's decline stood out in that company.

Autos faced their own cross-currents. Ford (NYSE:F) slipped on reports of an F-150 production cut, while General Motors rose. Higher yields have raised borrowing costs for auto loans, with the 10-year Treasury Yield touching its highest level since 2007 this week. The University of Michigan's consumer sentiment reading fell to a four-month low of 48.1, with the survey pointing to elevated fuel prices and trade disputes as risks to household spending.

Tracking the Two Timelines

Key items include any new date for the EU's Full Self-Driving vote, updates on Optimus production and progress on the Semi ramp. Tesla's quarterly figures, when scheduled, will show how the core car Business is holding up. The Shenzhen meetings in November could matter for Tesla's China exposure. Next week's PCE, ISM manufacturing, JOLTS and payrolls data will steer yields and auto financing costs.